Functional significance of aldehyde dehydrogenase ALDH1A1 to the nigrostriatal dopamine system

Brain Research

Volumn 1408, Issue , 2011, Pages 81-87

  Anderson, David W ^a   Schray, Rebecca C ^a   Duester, Gregg ^b   Schneider, Jay S ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

Aldehyde dehydrogenase; Dopamine; Microdialysis; Mouse

Indexed keywords

3,4 DIHYDROXYPHENYLACETALDEHYDE; 3,4 DIHYDROXYPHENYLACETIC ACID; ALDEHYDE; ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE 1A1; AMPHETAMINE; CATECHOLAMINE; DOPAMINE; DOPAMINE TRANSPORTER; NORADRENALIN; POTASSIUM CHLORIDE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER 2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE METABOLISM; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; GENE DELETION; MOUSE; NEUROTOXICITY; NONHUMAN; OXIDATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBSTANTIA NIGRA;

3,4-DIHYDROXYPHENYLACETIC ACID; ALDEHYDE DEHYDROGENASE; ANIMALS; CELL COUNT; CORPUS STRIATUM; DOPAMINE; DOPAMINERGIC NEURONS; GENOTYPE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRODIALYSIS; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

ANIMALIA;

EID: 80051550717     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.06.051     Document Type: Article

References (17)

1. J.D. Adams Jr., M.L. Chang, and L. Klaidman Parkinson's disease-redox mechanisms Curr. Med. Chem. 8 2001 809 814
2. D.W. Anderson, T. Neavin, J.A. Smith, and J.S. Schneider Neuroprotective effects of pramipexole in young and aged MPTP-treated mice Brain Res. 905 2001 44 53 (Pubitemid 32553837)
3. W.J. Burke, S.W. Li, E.A. Williams, R. Nonneman, and D.S. Zahm 3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis Brain Res. 989 2003 205 213 (Pubitemid 37211424)
4. V.G. Erwin, and R.A. Deitrich Brain aldehyde dehydrogenase. Localization, purification, and properties J. Biol. Chem. 241 1966 3533 3539
5. X. Fan, A. Molotkov, S.-I. Manabe, C.M. Donmoyer, L. Deltour, M.H. Foglio, A.E. Cuenca, W.S. Blaner, S.A. Lipton, and G. Duester Targeted disruption of Aldh1a1 (Raldh1) provides evidence for a complex mechanism of retinoic acid synthesis in the developing retina Mol. Cell. Biol. 23 2003 4637 4648 (Pubitemid 36734752)
6. D. Galter, S. Buervenich, A. Carmine, M. Anvret, and L. Olson ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia Neurobiol. Dis. 14 2003 637 647 (Pubitemid 37547970)
7. J. Grimm, A. Mueller, F. Hefti, and A. Rosenthal Molecular basis for catecholaminergic neuron diversity Proc. Natl. Acad. Sci. U. S. A. 101 2004 13891 13896 (Pubitemid 39298503)
8. E. Grunblatt, S. Mandel, J. Jacob-Hirsch, S. Zeligson, N. Amariglo, G. Rechavi, J. Li, R. Ravid, W. Roggendorf, P. Riederer, and M.B. Youdim Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes J. Neural Transm. 111 2004 1543 1573 (Pubitemid 40068786)
9. I. Lamensdorf, G. Eisenhofer, J. Harvey-White, A. Nechustan, K. Kirk, and I.J. Kopin 3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells Brain Res. 868 2000 191 201 (Pubitemid 30347515)
10. Y.S. Lau Measurement of dopamine uptake in neuronal cells and tissues Methods Mol. Med. 79 2003 465 471
11. S. Mandel, E. Grunblatt, P. Riederer, N. Amariglio, J. Jacob-Hirsch, G. Rechavi, and M.B. Youdim Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70 Ann. N. Y. Acad. Sci. 1053 2005 356 375 (Pubitemid 43031116)
12. J.A. Maring, R.A. Deitrich, and R. Little Partial purification and properties of human brain aldehyde dehydrogenases J. Neurochem. 45 1985 1903 1910 (Pubitemid 16204320)
13. + availability Chem. Res. Toxicol. 17 2004 1272 1279 (Pubitemid 39265884)
14. C.W. Olanow, and W.G. Tatton Etiology and pathogenesis of Parkinson's disease Annu. Rev. Neurosci. 22 1999 123 144 (Pubitemid 29144883)
15. A.H. Schapira, M. Gu, J.-W. Taanman, S.J. Tabrizi, T. Seaton, M. Cleeter, and J.M. Cooper Mitochondria in the etiology and pathogenesis of Parkinson's disease Ann. Neurol. 44 1998 S89 S98
16. A.W. Tank, H. Weiner, and J.A. Thurman Enzymology and subcellular localization of aldehyde oxidation in rat liver. Oxidation of 3,4-dihydroxyphenylacetaldehyde derived from dopamine to 3,4- dihydroxyphenylacetic acid Biochem. Pharmacol. 30 1981 3265 3275 (Pubitemid 12248329)
17. M. Westerlund, D. Galter, A. Carmine, and L. Olson Tissue-and species-specific expression patterns of class I, III, and IV Adh and Aldh 1 mRNAs in rodent embryos Cell Tissue Res. 322 2005 227 236 (Pubitemid 41679400)